Lung Cancer Clinical Trials in Massachusetts

Showing 501-520 of 555 trials

VX-710, Doxorubicin, and Vincristine for the Treatment of Patients With Recurrent Small Cell Lung Cancer

NCT00003847

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy for the treatment of patients who have recurrent small cell lung cancer following treatment.

Lung Cancer

Vertex Pharmaceuticals Incorporated36 participantsStarted Dec 1998

Little Rock, Arkansas, United States • Indianapolis, Indiana, United States • Boston, Massachusetts, United States +6 more locations

TERMINATEDPhase 318 miles

Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Patients With Stage III Non-small Cell Lung Cancer

NCT00004859

This randomized phase III trial is studying carboplatin, paclitaxel, radiation therapy, and thalidomide to see how well they work compared to carboplatin, paclitaxel, and radiation therapy alone in treating patients with newly diagnosed stage III non-small cell lung cancer. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Thalidomide may stop the growth of non-small cell lung cancer by stopping blood flow to the tumor. It is not yet known if combination chemotherapy plus radiation therapy is more effective with or without thalidomide.

Lung Cancer

National Cancer Institute (NCI)589 participantsStarted Jan 2000

Fort Smith, Arkansas, United States • Modesto, California, United States • Salinas, California, United States +233 more locations

VX-710, Doxorubicin, and Vincristine for the Treatment of Patients With Recurrent Small Cell Lung Cancer

Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Patients With Stage III Non-small Cell Lung Cancer

Lung Cancer Trials in Other Cities

Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer

Stereotactic Boost for Locally Advanced Non-Small Cell Lung Cancer

Airway Epithelium Gene Expression: AEGIS IDE

Dasatinib in Advanced Squamous Cell Lung Cancer

National Lung Screening Trial (NLST) Screening

Erlotinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

Does Moderate Intensity Exercise Help Prevent Smoking Relapse Among Women?

Cisplatin, Irinotecan, and Bevacizumab, in Treating Patients With Small Cell Lung Cancer

Phase 2b Study of Cetuximab With Platinum-Based Chemo as First Line Treatment of Recurrent or Advanced NSCLC

Pemetrexed and Best Supportive Care Versus Placebo and Best Supportive Care in Non-Small Cell Lung Cancer (NSCLC)

A Study Of AG-013736 (Axitinib) Or Bevacizumab (Avastin) In Combination With Paclitaxel And Carboplatin In Patients With Advanced Lung Cancer.

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Phase II Study of Brivanib (BMS-582664) to Treat Multiple Tumor Types

AZD6244 Versus Pemetrexed (Alimta®) in Patients With Non-small Cell Lung Cancer, Who Have Failed One or Two Prior Chemotherapy Regimen

A Study of Tarceva (Erlotinib) and Standard of Care Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC)

A Study of Avastin (Bevacizumab) in Combination With Carboplatin-Based Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer.

BB-10901 in Treating Patients With Relapsed or Refractory Solid Tumors

3-AP and Gemcitabine in Treating Patients With Metastatic Non-Small Cell Lung Cancer

Other Conditions in Massachusetts